Astellas Pharma Inc. and Pfizer Japan Inc. Release: Announcement of the Launch of the Selective COX-2 Inhibitor Celecox(R) Tablets in Japan

Published: Jun 11, 2007

Tokyo, June 11, 2007 (JCN Newswire) - Astellas Pharma Inc. and Pfizer Japan Inc. today announced that their selective COX-2 inhibitor Celecox(R)(generic name: celecoxib), a non-steroidal anti-inflammatory drug (NSAID), will become available in Japan on June 12, 2007, with the indication of "relief of inflammation and pain associated with rheumatoid arthritis (RA) and osteoarthritis (OA)".

Back to news